Company / Cost of Revenue
ARDELYX, INC. Cost of Revenue History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$39.5M
FY2025
5-year range
$1.0M / $50.6M
FY2021-FY2025
Trend
-21.8%
vs FY2024
Sector context
#56 of 85
Health Care
What the data says
At $40M, ARDELYX, INC.'s cost of revenue ranks #30 of 85 in the Health Care sector. Cost of Revenue has fluctuated over the past 9 years, ranging from $145,000 in FY2020 to $51M in FY2024.
Based on SEC 10-K filings.
$40M in FY2025 with a 5-year CAGR of +207.0%.
Increased from $18M to $40M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +112.6%
- 5-Year CAGR
- +207.0%
- 10-Year CAGR
- -
Sector benchmark
#30 of 85 in Health CareTop 34% of 85This company $39.5M Sector average $2.0B
▼
-98.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +207.0%, indicating consistent growth.
- In FY2025, cost of revenue decreased 21.8% year-over-year.
- Ranks #56 out of 85 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.5M | -21.8% |
| FY2024 | $50.6M | +184.1% |
| FY2023 | $17.8M | +332.2% |
| FY2022 | $4.1M | +311.7% |
| FY2021 | $1.0M | +589.7% |
| FY2020 | $145.0K | -75.8% |
| FY2019 | $600.0K | +28.8% |
| FY2018 | $466.0K | -94.5% |
| FY2017 | $8.4M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026